Stephen Tomlinson to Biological Products
This is a "connection" page, showing publications Stephen Tomlinson has written about Biological Products.
Connection Strength
0.042
-
A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor. Virol J. 2012 Nov 23; 9:285.
Score: 0.023
-
A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitor. Virol J. 2010 Feb 09; 7:30.
Score: 0.019